KRCT-1

N/A

Report date: 2025/01/26 18:44:36

NME

Base Information

Drug NameKRCT-1

Drug Alias NameTrk-A signaling inhibitor (Korea Institute of Radiological and Medical Sciences/University of Science and Technology)pyrazole compound (Korea Institute of Radiological and Medical Sciences/University of Science and Technology)KRCT-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNerve growth factor receptor Trk-A antagonists

TargetsNerve growth factor receptor Trk-A

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKorea Institute Of Radiological And Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Science and Technology, Korea Korea Institute Of Radiological And Medical Sciences

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A